These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4014243)

  • 21. Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability--FDA. Notice.
    Fed Regist; 1993 Jun; 58(105):31596-614. PubMed ID: 10171452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical research and the development of new devices: considerations for nurses.
    Lanter J
    Dimens Crit Care Nurs; 2007; 26(3):117-20. PubMed ID: 17440296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The MedWatch Program.
    Love L; Couig MP
    J Toxicol Clin Toxicol; 1999; 37(6):803-7. PubMed ID: 10584596
    [No Abstract]   [Full Text] [Related]  

  • 24. Health information technology and medical devices.
    Beyea SC
    AORN J; 2009 Mar; 89(3):603-5. PubMed ID: 19269385
    [No Abstract]   [Full Text] [Related]  

  • 25. Medical device accident reporting: does it improve patient safety?
    Nobel JJ
    Stud Health Technol Inform; 1996; 28():29-35. PubMed ID: 10172828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEDWATCH: the new FDA medical products reporting program.
    Kennedy DL
    Respir Care; 1993 Oct; 38(10):1077-80. PubMed ID: 10145891
    [No Abstract]   [Full Text] [Related]  

  • 27. EU and US clinical investigation adverse event reporting.
    Crowley G
    Med Device Technol; 2004 Jun; 15(5):30-2. PubMed ID: 15285486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDA releases Y2K list of critical medical devices.
    Hosp Peer Rev; 1999 Sep; 24(9):138, 143. PubMed ID: 10558180
    [No Abstract]   [Full Text] [Related]  

  • 29. Are you ready? FDA final rules on devices are on the way.
    Berek B
    Health Facil Manage; 1996 Sep; 9(9):56, 58, 60 passim. PubMed ID: 10160028
    [No Abstract]   [Full Text] [Related]  

  • 30. Reporting faulty medical devices.
    Hepplewhite DW
    Nursing; 1986 Nov; 16(11):46-7. PubMed ID: 3640263
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical devices; device tracking. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Feb; 67(27):5943-52. PubMed ID: 11838471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination products regulation at the FDA.
    Lauritsen KJ; Nguyen T
    Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA publishes list of Y2K high-risk medical equipment.
    Hosp Case Manag; 1999 Aug; 7(8):144-6. PubMed ID: 10557731
    [No Abstract]   [Full Text] [Related]  

  • 35. User reporting systems.
    Donawa ME
    Med Device Technol; 1997 Dec; 8(10):10-2. PubMed ID: 10176361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. License to maim: federal pre-emption and the Medical Device Amendments of 1976.
    Petrella ME
    Health Matrix Clevel; 1996; 6(2):349-89. PubMed ID: 10178392
    [No Abstract]   [Full Text] [Related]  

  • 37. Medical devices; procedures for investigational device exemptions--Food and Drug Administration. Final rule.
    Fed Regist; 1980 Jan; 45(13):3732-59. PubMed ID: 10248822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons learned from the Hospital Experience Reporting System.
    Beck WC; Geffert JP; Comella LH
    Med Instrum; 1983; 17(5):343-6. PubMed ID: 6646020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospitals served subpoenas in probe over medical devices.
    Burda D
    Mod Healthc; 1994 Jun; 24(25):4. PubMed ID: 10134477
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical devices; medical device distributor reporting; opportunity for comments--FDA. Final rule; opportunity for comments.
    Fed Regist; 1993 Sep; 58(168):46514. PubMed ID: 10128334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.